TransMedics Group, Inc. (TMDX) Tax Rate: -76.98%
Is TransMedics Group, Inc.’s tax rate high or low?
TransMedics Group, Inc.'s tax rate of -76.98% is 557% below its 5-year average of -11.72%, near the low end of its 5-year range (-76.98%–6.16%).
102.31% below its 12-month average of -38.05%.
TMDX Tax Rate Chart
TMDX Average Tax Rate Chart
TMDX Current vs Average Tax Rate Chart
TMDX Tax Rate Metrics
TAX RATE
-76.98%
TAX RATE AVG TTM
-38.05%
TAX RATE AVG 3Y
-17.53%
TAX RATE AVG 5Y
-11.72%
TAX RATE AVG 10Y
N/A
TAX RATE AVG 15Y
N/A
TAX RATE AVG 20Y
N/A
CURRENT VS TTM AVG
-102.31%
CURRENT VS 3Y AVG
-339.13%
CURRENT VS 5Y AVG
-556.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TransMedics Group, Inc. Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
TransMedics Group, Inc. Tax Rate FAQ
- What is the tax rate for TransMedics Group, Inc. (TMDX)?
- The tax rate for TMDX stock is -76.98%.
- Is TransMedics Group, Inc.'s tax rate high or low?
- TransMedics Group, Inc.'s tax rate of -76.98% is 557% below its 5-year average of -11.72%, near the low end of its 5-year range (-76.98%–6.16%).
- What is the TTM average tax rate for TransMedics Group, Inc. (TMDX)?
- The TTM average tax rate for TMDX stock is -38.05%.
- What is the 3Y average tax rate for TransMedics Group, Inc. (TMDX)?
- The 3Y average tax rate for TMDX stock is -17.53%.
- What is the 5Y average tax rate for TransMedics Group, Inc. (TMDX)?
- The 5Y average tax rate for TMDX stock is -11.72%.
TransMedics Group, Inc. Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2025-12-31 | -76.98% |
| 2024-12-31 | 0.88% |
| 2023-12-31 | 6.16% |
| 2022-12-31 | -0.18% |
| 2021-12-31 | -0.08% |
| 2020-12-31 | -0.11% |
| 2019-12-31 | -0.12% |
| 2018-12-31 | -0.17% |
| 2017-12-31 | -0.15% |
| 2016-12-31 | 0.00% |
Related Metrics
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein